DRKS00020551已完成未知
Safety and feasibility of a new psychotherapeutic intervention for secured acute psychiatric wards – MCT-A
niversitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Psychiatrie und PsychotherapieArbeitsgruppe Klinische Neuropsychologie0 个研究点目标入组 77 人开始时间: 2020年2月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 77
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Presence on a secured, closed acute psychiatric ward; diagnosis of a severe psychiatric illness (F diagnosis according to ICD-10)
排除标准
- •Inability to give informed consent / no consent from the legal guardian, lack of German language skills, mental retardation, and dementia
研究者
相似试验
已完成
2 期
A study on siddha medicine kumaara veeriya kaantha chenduram for anaemiaCTRI/2019/04/018795Ayothidoss Pandithar hospital30
尚未招募
2 期
Evaluation of safety and therapeutic efficacy of siddha drug KANDAAMALAGA ILAKAM in the treatment of Iron deficiency anaemia.CTRI/2018/05/014111Ayothidoss Pandithar Hospital
已完成
4 期
Evaluation of therapeutic efficacy and safety of artesunate-amodiaquine, artemether-lumefantrine and dihydroartemisinine-piperaquine for the treatment of uncomplicated Plasmodium falciparum in Democratic Republic of CongoInfection - Studies of infection and infectious agentsMalariaACTRN12616001423404Ministry of Health534
进行中（未招募）
1 期
Study of the safety and effectiveness of drug AZD4017 at reducing pressure in the brain, in idiopathic intracranial hypertension.MedDRA version: 18.0Level: PTClassification code 10004277Term: Benign intracranial hypertensionSystem Organ Class: 10029205 - Nervous system disordersIdiopathic Intracranial HypertensionEUCTR2013-003643-31-GBniversity of Birmingham30
尚未招募
2 期
VALERGEN-combination of routes- Asthma-Adults-Phase IIAsthmaBronchial DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesEnvironmental IllnessRPCEC00000298ational Center of Bioproducts (BioCen)180